Myriad Genetics - 24 Year Stock Price History | MYGN

Historical daily share price chart and data for Myriad Genetics since 1995 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Myriad Genetics as of February 19, 2019 is 31.48.
Myriad Genetics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 29.0958 29.0000 31.4800 26.9300 31.4800 8.29%
2018 37.0251 34.9100 50.3400 27.2300 29.0700 -15.36%
2017 25.3318 16.9300 37.1400 15.4000 34.3450 106.03%
2016 28.9086 42.8300 42.8300 16.2600 16.6700 -61.38%
2015 36.9074 34.6100 46.1600 30.9400 43.1600 26.72%
2014 35.2888 21.7200 42.2100 21.0300 34.0600 62.35%
2013 27.1721 27.6800 34.2600 20.7900 20.9800 -23.01%
2012 25.3547 21.0000 30.6500 20.3600 27.2500 30.13%
2011 20.8191 22.2300 25.5300 17.8600 20.9400 -8.32%
2010 19.8918 26.6600 26.9200 14.4900 22.8400 -12.46%
2009 31.4194 32.5829 43.8378 22.8500 26.0900 -17.37%
2008 25.1092 21.9856 33.8456 16.5726 31.5727 42.74%
2007 19.6255 14.9382 28.0323 14.8810 22.1190 48.31%
2006 12.2075 10.3019 15.0335 10.0446 14.9144 50.48%
2005 9.2405 10.5401 12.3318 7.2428 9.9111 -7.60%
2004 7.9792 6.4708 11.3931 5.8085 10.7260 75.04%
2003 6.1286 7.1522 8.5388 4.0979 6.1278 -11.92%
2002 11.7849 24.0107 24.0107 6.3612 6.9569 -72.26%
2001 24.3898 33.1166 36.8094 12.3556 25.0828 -36.39%
2000 31.2656 10.8999 61.2299 9.8873 39.4302 259.78%
1999 3.4556 2.5326 11.1977 2.0549 10.9594 360.00%
1998 3.7612 5.7775 6.0158 1.7869 2.3825 -58.76%
1997 6.6744 5.7775 10.8117 5.1819 5.7775 -3.96%
1996 6.1546 7.0283 8.3983 4.1098 6.0158 -22.62%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.305B $0.773B
Myriad Genetics, Inc. is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties. Myriad is the pioneer and leader in molecular diagnostics, offering innovative products that transform patients' lives. These products include leading molecular diagnostic tests for hereditary cancer, urological cancer, lung cancer, autoimmune disorders and other diseases. Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. Myriad's hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care. Myriad is expanding their reach and increasing their impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.200B 13.07
Gilead Sciences (GILD) United States $87.436B 10.97
Biogen (BIIB) United States $65.478B 12.69
Celgene (CELG) United States $63.576B 11.78
Vertex Pharmaceuticals (VRTX) United States $48.081B 64.41
Regeneron Pharmaceuticals (REGN) United States $46.330B 21.52
Illumina (ILMN) United States $44.074B 52.42
Alexion Pharmaceuticals (ALXN) United States $28.921B 17.92
Incyte (INCY) United States $18.013B 168.30
BioMarin Pharmaceutical (BMRN) United States $16.736B 0.00
Seattle Genetics (SGEN) United States $11.477B 0.00
Exact Sciences (EXAS) United States $10.883B 0.00
Sarepta Therapeutics (SRPT) United States $9.252B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.876B 0.00
QIAGEN (QGEN) Netherlands $8.819B 28.84
BeiGene (BGNE) Cayman Islands $7.856B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bluebird Bio (BLUE) United States $7.495B 0.00
Bio-Techne Corp (TECH) United States $7.237B 48.76
Moderna (MRNA) United States $7.053B 0.00
Exelixis (EXEL) United States $6.655B 15.57
Amarin (AMRN) Ireland $5.703B 0.00
Galapagos (GLPG) Belgium $5.283B 0.00
Alkermes (ALKS) Ireland $5.078B 0.00
Array BioPharma (ARRY) United States $5.047B 0.00
Guardant Health (GH) United States $4.379B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.077B 0.00
Horizon Pharma Public (HZNP) Ireland $3.884B 15.98
Allogene Therapeutics (ALLO) United States $3.795B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.458B 0.00
Emergent Biosolutions (EBS) United States $3.371B 28.40
Blueprint Medicines (BPMC) United States $3.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.286B 0.00
Ascendis Pharma (ASND) Denmark $3.087B 0.00
Genomic Health (GHDX) United States $3.011B 101.63
ACADIA Pharmaceuticals (ACAD) United States $2.908B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.865B 0.00
Global Blood Therapeutics (GBT) United States $2.722B 0.00
Immunomedics (IMMU) United States $2.710B 0.00
China Biologic Products (CBPO) China $2.701B 19.23
Repligen (RGEN) United States $2.640B 82.45
Ligand Pharmaceuticals (LGND) United States $2.569B 18.45
Reata Pharmaceuticals (RETA) United States $2.566B 0.00
Mirati Therapeutics (MRTX) United States $2.496B 0.00
Akcea Therapeutics (AKCA) United States $2.472B 0.00
Arena Pharmaceuticals (ARNA) United States $2.466B 0.00
Halozyme Therapeutics (HALO) United States $2.463B 54.97
Amicus Therapeutics (FOLD) United States $2.162B 0.00
Insmed (INSM) United States $2.087B 0.00
Spark Therapeutics (ONCE) United States $1.992B 0.00
Denali Therapeutics (DNLI) United States $1.991B 0.00
Acceleron Pharma (XLRN) United States $1.961B 0.00
Atara Biotherapeutics (ATRA) United States $1.846B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.830B 0.00
Medicines (MDCO) United States $1.830B 0.00
AnaptysBio (ANAB) United States $1.828B 0.00
REGENXBIO (RGNX) United States $1.725B 23.14
MyoKardia (MYOK) United States $1.719B 0.00
NeoGenomics (NEO) United States $1.649B 135.69
CRISPR Therapeutics AG (CRSP) Switzerland $1.636B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.630B 0.00
Myovant Sciences (MYOV) United Kingdom $1.509B 0.00
Innoviva (INVA) United States $1.497B 4.13
Allakos (ALLK) United States $1.468B 0.00
Aimmune Therapeutics (AIMT) United States $1.422B 0.00
UniQure (QURE) Netherlands $1.396B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
ALECTOR INC (ALEC) United States $1.352B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.347B 0.00
Clovis Oncology (CLVS) United States $1.344B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.282B 0.00
Lion Biotechnologies (IOVA) United States $1.272B 0.00
Cambrex (CBM) United States $1.266B 13.65
GOSSAMER BIO (GOSS) United States $1.221B 0.00
Codexis (CDXS) United States $1.184B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.172B 0.00
WAVE Life Sciences (WVE) Singapore $1.108B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.107B 44.92
Rubius Therapeutics (RUBY) United States $1.104B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.092B 0.00
Audentes Therapeutics (BOLD) United States $1.055B 0.00
Puma Biotechnology (PBYI) United States $1.055B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.034B 0.00
Epizyme (EPZM) United States $1.020B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.978B 0.00
Editas Medicine (EDIT) United States $0.960B 0.00
Fate Therapeutics (FATE) United States $0.960B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Coherus BioSciences (CHRS) United States $0.948B 0.00
Sangamo Therapeutics (SGMO) United States $0.897B 0.00
Retrophin (RTRX) United States $0.889B 0.00
Athenex (ATNX) United States $0.846B 0.00
Vericel (VCEL) United States $0.845B 0.00
CytomX Therapeutics (CTMX) United States $0.829B 0.00
Novavax (NVAX) United States $0.815B 0.00
G1 THERAPEUTICS (GTHX) United States $0.781B 0.00
Apellis Pharmaceuticals (APLS) United States $0.778B 0.00
InflaRx (IFRX) Germany $0.777B 0.00
Arvinas (ARVN) United States $0.770B 0.00
Intra-Cellular Therapies (ITCI) United States $0.765B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.761B 0.00
Heska (HSKA) United States $0.743B 60.84
Cellectis (CLLS) France $0.726B 0.00
Principia Biopharma (PRNB) United States $0.723B 0.00
ANI Pharmaceuticals (ANIP) United States $0.722B 13.81
Dicerna Pharmaceuticals (DRNA) United States $0.718B 0.00
Dynavax Technologies (DVAX) United States $0.698B 0.00
Acorda Therapeutics (ACOR) United States $0.680B 8.83
Cara Therapeutics (CARA) United States $0.670B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.663B 0.00
Revance Therapeutics (RVNC) United States $0.654B 0.00
RA PHARMCTL INC (RARX) United States $0.650B 0.00
Viking Therapeutics (VKTX) United States $0.648B 0.00
Twist Bioscience (TWST) United States $0.643B 0.00
Intellia Therapeutics (NTLA) United States $0.607B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.577B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
UROGEN PHARMA (URGN) Israel $0.565B 0.00
Kura Oncology (KURA) United States $0.564B 0.00
Eidos Therapeutics (EIDX) United States $0.563B 0.00
Anika Therapeutics (ANIK) United States $0.562B 23.25
Osiris Therapeutics (OSIR) United States $0.550B 0.00
Synthorx (THOR) United States $0.546B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.542B 0.00
Arcus Biosciences (RCUS) United States $0.529B 0.00
Prothena (PRTA) Ireland $0.524B 0.00
Zymeworks (ZYME) Canada $0.502B 0.00
PDL BioPharma (PDLI) United States $0.486B 7.93
UNITY Biotechnology (UBX) $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.466B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.465B 0.00
Scholar Rock Holding (SRRK) United States $0.462B 0.00
ObsEva SA (OBSV) Switzerland $0.451B 0.00
DBV Technologies (DBVT) France $0.450B 0.00
Zealand Pharma (ZEAL) Denmark $0.450B 4.96
Senesco Technologies (ELOX) United States $0.446B 0.00
Replimune (REPL) United States $0.445B 0.00
Agenus (AGEN) United States $0.433B 0.00
Cytokineticsorporated (CYTK) United States $0.432B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.424B 0.00
Kezar Life Sciences (KZR) United States $0.420B 0.00
Five Prime Therapeutics (FPRX) United States $0.411B 0.00
OSMOTICA PHARM (OSMT) United States $0.406B 0.00
BeyondSpring (BYSI) United States $0.404B 0.00
Mesoblast (MESO) Australia $0.398B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.373B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.369B 0.00
Kindred Biosciences (KIN) United States $0.367B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
AVROBIO (AVRO) United States $0.367B 0.00
Stemline Therapeutics (STML) United States $0.365B 0.00
Cellular Biomedicine (CBMG) United States $0.360B 0.00
Inovio Pharmaceuticals (INO) United States $0.353B 0.00
MeiraGTx Holdings (MGTX) United States $0.350B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
Gritstone Oncology (GRTS) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.332B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.330B 0.00
BioDelivery Sciences (BDSI) United States $0.328B 0.00
MediciNova (MNOV) United States $0.322B 0.00
Aduro Biotech (ADRO) United States $0.322B 0.00
Abeona Therapeutics (ABEO) United States $0.318B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
Urovant Sciences (UROV) United States $0.314B 0.00
XBiotech (XBIT) United States $0.310B 0.00
Constellation Pharmaceuticals (CNST) United States $0.308B 0.00
Magenta Therapeutics (MGTA) United States $0.306B 0.00
Evelo Biosciences (EVLO) United States $0.293B 0.00
Enochian BioSciences (ENOB) United States $0.287B 0.00
Sorrento Therapeutics (SRNE) United States $0.285B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
Solid Biosciences (SLDB) United States $0.283B 0.00
Axsome Therapeutics (AXSM) United States $0.278B 0.00
Geron (GERN) United States $0.274B 0.00
Intec Pharma (NTEC) Israel $0.269B 0.00
AC Immune SA (ACIU) Switzerland $0.261B 0.00
Kadmon Holdings (KDMN) United States $0.259B 0.00
Merus (MRUS) Netherlands $0.258B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.254B 0.00
Kodiak Sciences (KOD) United States $0.252B 0.00
Seres Therapeutics (MCRB) United States $0.250B 0.00
Liquidia Technologies (LQDA) United States $0.247B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.247B 0.00
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
Verastem (VSTM) United States $0.244B 0.00
Celcuity (CELC) United States $0.241B 0.00
Adverum Biotechnologies (ADVM) United States $0.240B 0.00
Synlogic (SYBX) United States $0.236B 0.00
Kamada (KMDA) Israel $0.236B 10.64
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
MannKind (MNKD) United States $0.231B 0.00
Syros Pharmaceuticals (SYRS) United States $0.231B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.225B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.221B 0.00
TOCAGEN INC (TOCA) United States $0.219B 0.00
Athersys (ATHX) United States $0.217B 0.00
Arbutus Biopharma (ABUS) Canada $0.215B 0.00
LogicBio Therapeutics (LOGC) United States $0.209B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
Cerecor (CERC) United States $0.207B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.204B 0.00
Celyad SA (CYAD) Belgium $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.196B 0.00
Aptinyx (APTX) United States $0.189B 0.00
Compugen (CGEN) Israel $0.186B 0.00
Axovant Sciences (AXGT) United Kingdom $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Protagonist Therapeutics (PTGX) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.166B 0.00
Menlo Therapeutics (MNLO) United States $0.164B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.159B 0.00
VBI Vaccines (VBIV) United States $0.157B 0.00
Mersana Therapeutics (MRSN) United States $0.156B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.151B 0.00
Proteostasis Therapeutics (PTI) United States $0.149B 0.00
OvaScience (MLND) United States $0.145B 0.00
Allena Pharmaceuticals (ALNA) United States $0.143B 0.00
Cohbar (CWBR) United States $0.137B 0.00
BioXcel Therapeutics (BTAI) United States $0.136B 0.00
Cue Biopharma (CUE) United States $0.134B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.133B 0.00
Unum Therapeutics (UMRX) United States $0.129B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Trevena (TRVN) United States $0.127B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
Mustang Bio (MBIO) United States $0.122B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.121B 0.00
Checkpoint Therapeutics (CKPT) United States $0.121B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
XOMA (XOMA) United States $0.118B 0.00
Equillium (EQ) United States $0.113B 0.00
Catalyst Biosciences (CBIO) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
VTv Therapeutics (VTVT) United States $0.097B 0.00
Chiasma (CHMA) United States $0.095B 0.00
Neothetics (EVFM) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.091B 0.00
NantKwest (NK) United States $0.090B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.082B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.078B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.077B 0.00
Alimera Sciences (ALIM) United States $0.076B 0.00
Provention Bio (PRVB) United States $0.075B 0.00
PHASEBIO PHARMA (PHAS) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
INMUNE BIO INC (INMB) United States $0.070B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Celldex Therapeutics (CLDX) United States $0.067B 0.00
SESEN BIO, INC (SESN) United States $0.065B 0.00
AEterna Zentaris (AEZS) United States $0.065B 12.28
Sienna Biopharmaceuticals (SNNA) United States $0.062B 0.00
OVID THERAPEUTC (OVID) United States $0.062B 0.00
Prima BioMed (IMMP) Australia $0.060B 0.00
Applied Genetic Technologies (AGTC) United States $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.058B 0.00
Ophthotech (OPHT) United States $0.058B 0.00
Proteon Therapeutics (PRTO) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Entera Bio (ENTX) Israel $0.054B 0.00
VIVUS (VVUS) United States $0.054B 0.00
ScPharmaceuticals (SCPH) United States $0.053B 0.00
ARAVIVE, INC (ARAV) United States $0.053B 4.67
Alcobra (ARCT) United States $0.053B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Selecta Biosciences (SELB) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Celsion (CLSN) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
OncoSec Medical (ONCS) United States $0.041B 0.00
Moleculin Biotech (MBRX) United States $0.040B 0.00
Motif Bio Plc (MTFB) United States $0.040B 0.00
Arsanis (ASNS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.034B 5.58
Curis (CRIS) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Galena Biopharma (SLS) United States $0.031B 0.00
AZURRX BIOPHARM (AZRX) United States $0.031B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.031B 0.00
Adial Pharmaceuticals (ADIL) United States $0.030B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.028B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
GTx (GTXI) United States $0.023B 0.00
Vical (VICL) United States $0.022B 0.00
CytRx (CYTR) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.020B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.014B 7.25
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
Histogenics (HSGX) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00